Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ICOSAPENT for Hypertriglyceridaemia: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 24 adverse event reports in the FDA FAERS database where ICOSAPENT was used for Hypertriglyceridaemia.

Most Reported Side Effects for ICOSAPENT

Side Effect Reports % Deaths Hosp.
Hepatotoxicity 36 29.3% 0 33
Drug-induced liver injury 35 28.5% 0 34
Hepatic cirrhosis 33 26.8% 0 33
Hepatic encephalopathy 33 26.8% 0 33
Hepatic necrosis 33 26.8% 0 33
Drug interaction 29 23.6% 0 29
Drug ineffective 24 19.5% 0 21
Hypertriglyceridaemia 16 13.0% 1 16
Myocardial infarction 15 12.2% 0 15
Coronary artery disease 12 9.8% 0 12
Acute myocardial infarction 9 7.3% 0 9
Cerebrovascular accident 9 7.3% 0 9
Hypertransaminasaemia 9 7.3% 1 9
Gastrointestinal disorder 7 5.7% 1 7
Increased appetite 7 5.7% 0 6

Other Indications for ICOSAPENT

Product used for unknown indication (65) Low density lipoprotein (5)

Other Drugs Used for Hypertriglyceridaemia

FENOFIBRATE (517) ATORVASTATIN (117) OMEGA-3-CARBOXYLIC ACIDS (116) GEMFIBROZIL (112) ICOSAPENT ETHYL (98) EVOLOCUMAB (70) OMEGA-3-ACID ETHYL ESTERS (58) ROSUVASTATIN (54) ALIROCUMAB (51) OMEGA-3 FATTY ACIDS (43)

Related Pages

ICOSAPENT Full Profile All Hypertriglyceridaemia Drugs ICOSAPENT Demographics ICOSAPENT Timeline